Tissue Repair Ltd (TRP.AX)
AUD 0.24
(0.0%)
AUD 0.24
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 152.24 Thousand AUD | 4849.28% |
| 2023 | 3076.00 AUD | -98.21% |
| 2022 | 171.92 Thousand AUD | 12.63% |
| 2021 | 152.63 Thousand AUD | 97743.59% |
| 2020 | 156.00 AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | 866.13 Thousand AUD | 0.0% |
| 2024 Q2 | 58.58 Thousand AUD | 100.0% |
| 2024 Q1 | 29.29 Thousand AUD | 852.31% |
| 2024 FY | 152.24 Thousand AUD | 4849.28% |
| 2024 Q3 | 866.13 Thousand AUD | 1378.4% |
| 2023 Q1 | - AUD | -100.0% |
| 2023 FY | 3076.00 AUD | -98.21% |
| 2023 Q4 | 3076.00 AUD | -99.37% |
| 2023 Q3 | 485.82 Thousand AUD | 0.0% |
| 2023 Q2 | - AUD | 0.0% |
| 2022 FY | 171.92 Thousand AUD | 12.63% |
| 2022 Q4 | 85.96 Thousand AUD | 0.0% |
| 2022 Q3 | 85.96 Thousand AUD | 0.0% |
| 2022 Q2 | - AUD | 0.0% |
| 2022 Q1 | - AUD | -100.0% |
| 2021 Q1 | - AUD | 0.0% |
| 2021 FY | 152.63 Thousand AUD | 97743.59% |
| 2021 Q4 | 76.31 Thousand AUD | 0.0% |
| 2021 Q3 | 76.31 Thousand AUD | 0.0% |
| 2021 Q2 | - AUD | 0.0% |
| 2020 FY | 156.00 AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AdAlta Limited | 1.73 Million AUD | 91.239% |
| Acrux Limited | 5.09 Million AUD | 97.01% |
| Race Oncology Limited | 4 Million AUD | 96.197% |
| Biome Australia Limited | 13 Million AUD | 98.83% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | 74.703% |
| BTC Health Limited | 16.36 Thousand AUD | -830.562% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 97.959% |
| CSL Limited | 22.41 Billion AUD | 99.999% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 98.677% |
| Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 99.827% |
| EZZ Life Science Holdings Limited | 66.44 Million AUD | 99.771% |
| Hexima Limited | - AUD | -Infinity% |
| Immutep Limited | 3.5 Million AUD | 95.657% |
| Memphasys Limited | 60 Thousand AUD | -153.733% |
| Neuren Pharmaceuticals Limited | 231.92 Million AUD | 99.934% |
| Noxopharm Limited | 2.4 Million AUD | 93.657% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 95.899% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | 49.122% |
| Starpharma Holdings Limited | 8.28 Million AUD | 98.163% |
| Biotron Limited | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 4.01 Million AUD | 96.212% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Bio-Gene Technology Limited | 18.32 Thousand AUD | -731.004% |
| Zelira Therapeutics Limited | 94.95 Thousand AUD | -60.334% |
| Patrys Limited | 1.39 Million AUD | 89.08% |
| Orthocell Limited | 5.31 Million AUD | 97.136% |
| Imugene Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | 22.05 Million AUD | 99.31% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | 82.935% |
| Cynata Therapeutics Limited | 2.31 Million AUD | 93.426% |
| Arovella Therapeutics Limited | 17 Thousand AUD | -795.529% |
| Nanollose Limited | 12.5 Thousand AUD | -1117.823% |
| Invex Therapeutics Ltd | 1.21 Million AUD | 87.442% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 4.45 Million AUD | 96.581% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | 87.836% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 496.65 Million AUD | 99.969% |
| Dimerix Limited | 583.47 Thousand AUD | 73.908% |
| PharmAust Limited | - AUD | -Infinity% |
| AnteoTech Limited | 460.39 Thousand AUD | 66.933% |
| Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | -131.368% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Avecho Biotechnology Limited | 473.55 Thousand AUD | 67.851% |
| Actinogen Medical Limited | 9.93 Million AUD | 98.467% |
| Immuron Limited | 4.9 Million AUD | 96.895% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 94.14% |